ALX Oncology Holdings Inc.
ALXO
$2.11
-$0.07-3.21%
NASDAQ
| 06/30/2025 | 03/31/2025 | 12/31/2024 | 09/30/2024 | 06/30/2024 | |
|---|---|---|---|---|---|
| Net Income | 15.62% | -5.46% | 5.03% | 22.06% | -10.73% |
| Total Depreciation and Amortization | -9.48% | -1.40% | -4.46% | 1.82% | 2.80% |
| Total Amortization of Deferred Charges | 2.99% | -2.90% | 4.55% | 0.00% | 3.13% |
| Total Other Non-Cash Items | 5.55% | -7.62% | -12.09% | 0.41% | 6.74% |
| Change in Net Operating Assets | -591.78% | 107.36% | -562.63% | -121.29% | 172.56% |
| Cash from Operations | 5.10% | 23.04% | -26.28% | 4.48% | 29.95% |
| Capital Expenditure | 21.67% | 0.00% | 59.73% | -65.56% | 39.19% |
| Sale of Property, Plant, and Equipment | -- | -- | -- | -- | -- |
| Cash Acquisitions | -- | -- | -- | -- | -- |
| Divestitures | -- | -- | -- | -- | -- |
| Other Investing Activities | -19.28% | -16.66% | 28.64% | 2,491.98% | -96.25% |
| Cash from Investing | -19.28% | -16.69% | 29.15% | 2,732.75% | -96.57% |
| Total Debt Issued | -- | -- | -- | -- | -- |
| Total Debt Repaid | 22.80% | -303.95% | 78.77% | -64.22% | -24.57% |
| Issuance of Common Stock | -95.97% | 726.67% | -- | -- | 739.31% |
| Repurchase of Common Stock | -- | -- | -- | -- | -- |
| Issuance of Preferred Stock | -- | -- | -- | -- | -- |
| Repurchase of Preferred Stock | -- | -- | -- | -- | -- |
| Total Dividends Paid | -- | -- | -- | -- | -- |
| Other Financing Activities | -- | -- | -98.81% | -- | -- |
| Cash from Financing | -441.54% | -80.18% | 30.68% | -99.08% | 779.84% |
| Foreign Exchange rate Adjustments | -- | -- | -- | -- | -- |
| Miscellaneous Cash Flow Adjustments | -- | -- | -- | -- | -- |
| Net Change in Cash | -143.06% | 107.99% | 157.92% | -61.96% | 117.85% |